Skip to main content

Breast Transdisciplinary Cancer Team

The goal of the Breast Transdisciplinary Cancer Team is to bring expertise from different disciplines in basic and clinical research to advance our understanding of breast cancer and to translate that information to clinical trials to improve patient care in South Carolina.

The team consists of members with expertise in basic biology, oncology, pathology, surgery, population science, pharmacology, engineering, and informatics and biostatistics.

Co-Leaders

Nancy Klauber-DeMore, M.D.

Co-Leader, Developmental Cancer Therapeutics Program, MUSC Hollings Cancer Center
Director, Medical Scientist Training Program
BMW Endowed Chair in Cancer Research
Professor, Surgery

Ozgur Sahin, Ph.D.

Co-Leader, Cancer Biology & Immunology Program, MUSC Hollings Cancer Center
HART Program Director, Basic Science Translation, MUSC Hollings Cancer Center
SmartState Endowed Chair, Lipidomics, Pathobiology & Therapy
Professor, Biochemistry & Molecular Biology

Team Members

Hollings Members

Peggi Angel, Ph.D.
Lauren Ball, Ph.D.
Hazel Breland, Ph.D.
Joseph Delaney, Ph.D.
Toros Dincman, M.D., Ph.D.
Richard Drake, Ph.D.
Scott Eblen, Ph.D.
Stephen Ethier, Ph.D.
Marvella Ford, Ph.D.
Wenjian Gan, Ph.D.
Saverio Gentile, Ph.D.
Dieter Haemmerich, Ph.D.
Elizabeth Hill, Ph.D.

Philip Howe, Ph.D.
Carsten Krieg, Ph.D.
Amanda LaRue, Ph.D.
David Long, Ph.D.
Shikhar Mehrotra, Ph.D.
Anand Mehta, Ph.D.
Bidyut Mohanty, Ph.D.
Robin Muise-Helmericks, Ph.D.
Besim Ogretmen, Ph.D.
Michael Ostrowski, Ph.D.
Subramanya Pandruvada, Ph.D.
Yong (Gavin) Wang, M.D., Ph.D.